Roche Holding Ltd logo

Roche Holding Ltd

Stock
Stock
ISIN: CH1499059983
Ticker: ROP
CH1499059983
ROP

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

Roche Holding Ltd has so far distributed $12.43 in 2026. The next dividend will be paid on 16.03.2027


$4.913

CHART BY

Frequently asked questions

The market capitalization of Roche Holding Ltd is $348.16B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for Roche Holding Ltd is 23.12. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
Roche Holding Ltd's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $18.93. EPS indicates the company's profitability on a per-share basis.
Currently, 25 analysts cover Roche Holding Ltd's stock, with a consensus target price of $461.85. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Roche Holding Ltd reported a revenue of $74.40B.
Roche Holding Ltd's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $26.94B. EBITDA measures the company's overall financial performance.
Roche Holding Ltd has a free cash flow of $18.02B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Roche Holding Ltd employs approximately 112,774 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
The free float of Roche Holding Ltd is 688.93M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$348.16B
EPS (TTM) 
$18.93
Free Float 
688.93M
P/E ratio (TTM) 
23.12
Revenue (TTM) 
$74.40B
EBITDA (TTM) 
$26.94B
Free Cashflow (TTM) 
$18.02B

Pricing

1D span
$438.20$445.26
52W span
$316.08$484.43

Analyst Ratings

The price target is $461.85 and the stock is covered by 25 analysts.

Buy

14

Hold

9

Sell

2

Information

Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics, and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Employees
112,774
Industries
Major Pharmaceuticals
Sector
Health Care

Identifier

ISIN
CH1499059983
Primary Ticker
ROP

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation